17/05/2025
🎗️ Breakthrough in Breast Cancer Treatment: Pertuzumab 420mg Injection 🎗️
In the fight against HER2-positive breast cancer, one name continues to stand out: Pertuzumab 420mg — a targeted therapy that has delivered remarkable results in improving survival outcomes, especially when used alongside trastuzumab and chemotherapy.
Pertuzumab 420mg: $999 per vial
Trastuzumab 440mg: $199 per vial
TCH-P Protocol: $1399 (All 4 medicines as per dose)
âś… Clinical results show:
Enhanced progression-free survival
Improved overall response rates
Synergistic action with other HER2-targeted therapies
Better outcomes in both neoadjuvant and metastatic settings
🌍 And here’s the game-changer:
While this therapy can be prohibitively expensive in many parts of the world, accessing Pertuzumab from India can bring the cost down significantly — available at approximately $999 per vial via licensed and compliant pharmaceutical exporters.
💡 For patients, oncologists, and healthcare providers around the world, this opens doors to affordable, high-quality cancer care — without compromising on treatment standards.
📢 India continues to be a vital hub for affordable access to life-saving cancer medications — not just a manufacturer, but a lifeline.
If you're a patient advocate, oncologist, or health organization looking for trusted access points — we’re here to help.
For more information: Opsan and Remedazo
hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag